We Can Medicines Co., Ltd. (TPEX:6929)

Taiwan · Delayed Price · Currency is TWD

24.60

+0.10 (0.41%)

Jun 18, 2026, 9:05 AM CST

-27.22% (1Y)

Market Cap	1.11B -27.1%
Revenue (ttm)	3.22B -0.9%
Net Income	-70.40M
EPS	-1.56
Shares Out	45.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,224
Open	24.60
Previous Close	24.50
Day's Range	24.60 - 24.60
52-Week Range	21.05 - 36.50
Beta	-0.59
Analysts	Hold
Price Target	70.00 (+184.55%)
Earnings Date	Aug 7, 2026

About We Can Medicines

We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and baby product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered in Taichung, Taiwan. We Can Medicines Co., Ltd. operates as a subsidiary of Yousheng Medical Technology Co., Ltd. [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1972

Employees 1,020

Stock Exchange Taipei Exchange

Ticker Symbol 6929

Full Company Profile

Financial Performance

In 2025, We Can Medicines's revenue was 3.22 billion, a decrease of -1.45% compared to the previous year's 3.27 billion. Losses were -73.21 million, 55.2% more than in 2024.

Financial Statements